Endurant Capital Management LP Insmed Inc Transaction History

Endurant Capital Management LP

$0
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $2.47 Million - $3.18 Million	-150,535 Reduced 65.45%	79,471 $1.68 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $213,266 - $285,010	-13,116 Reduced 5.39%	230,006 $3.92 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $2.3 Million - $3.13 Million	135,409 Added 125.71%	243,122 $4.86 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $717,395 - $969,239	-34,358 Reduced 24.18%	107,713 $2.32 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $396,177 - $596,703	-23,209 Reduced 14.04%	142,071 $2.8 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $1.55 Million - $2.14 Million	76,069 Added 85.27%	165,280 $3.88 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $1.83 Million - $2.36 Million	-70,692 Reduced 44.21%	89,211 $2.43 Million
Q3 2021 Nov 15, 2021	SELL	$22.46 - $29.47 $2.26 Million - $2.96 Million	-100,411 Reduced 38.57%	159,903 $4.4 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $3.09 Million - $4.61 Million	127,892 Added 96.58%	260,314 $7.41 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $261,435 - $358,785	8,099 Added 6.51%	132,422 $4.51 Million
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $628,685 - $810,394	-19,990 Reduced 13.85%	124,323 $4.14 Million
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $107,354 - $142,450	4,129 Added 2.95%	144,313 $4.64 Million
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $928,706 - $1.94 Million	65,819 Added 88.51%	140,184 $3.86 Million
Q1 2020 May 15, 2020	BUY	$13.63 - $33.98 $1.01 Million - $2.53 Million	74,365 New	74,365 $1.19 Million
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $496,917 - $755,800	-22,910 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $1.92 Million - $2.3 Million	-72,490 Reduced 75.99%	22,910 $714,000
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.11 Million - $2.98 Million	95,400	95,400 $2.98 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.27 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$1.05 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$929 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$775 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$482 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Account